Premier PE Ratio 2012-2025 | PINC
Current and historical p/e ratio for Premier (PINC) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Premier PE ratio as of June 12, 2025 is 14.06.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Premier PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-12 | 22.53 | 39.53 | |
| 2025-03-31 | 19.10 | $0.57 | 33.52 |
| 2024-12-31 | 20.76 | $-0.10 | 0.00 |
| 2024-09-30 | 19.41 | $1.36 | 14.27 |
| 2024-06-30 | 17.93 | $1.03 | 17.41 |
| 2024-03-31 | 20.99 | $0.64 | 32.79 |
| 2023-12-31 | 21.02 | $1.39 | 15.12 |
| 2023-09-30 | 20.01 | $1.48 | 13.52 |
| 2023-06-30 | 25.49 | $1.47 | 17.34 |
| 2023-03-31 | 29.59 | $1.54 | 19.21 |
| 2022-12-31 | 31.77 | $1.47 | 21.61 |
| 2022-09-30 | 30.63 | $1.55 | 19.76 |
| 2022-06-30 | 32.01 | $2.16 | 14.82 |
| 2022-03-31 | 31.76 | $2.31 | 13.75 |
| 2021-12-31 | 36.53 | $2.38 | 15.35 |
| 2021-09-30 | 34.22 | $2.12 | 16.14 |
| 2021-06-30 | 30.55 | $2.57 | 11.89 |
| 2021-03-31 | 29.56 | $1.86 | 15.89 |
| 2020-12-31 | 30.48 | $2.01 | 15.16 |
| 2020-09-30 | 28.35 | $-5.22 | 0.00 |
| 2020-06-30 | 29.43 | $-6.15 | 0.00 |
| 2020-03-31 | 28.09 | $-10.49 | 0.00 |
| 2019-12-31 | 32.52 | $-10.55 | 0.00 |
| 2019-09-30 | 24.83 | $-2.99 | 0.00 |
| 2019-06-30 | 33.57 | $-16.28 | 0.00 |
| 2019-03-31 | 29.61 | $-17.80 | 0.00 |
| 2018-12-31 | 32.06 | $-20.21 | 0.00 |
| 2018-09-30 | 39.30 | $-18.88 | 0.00 |
| 2018-06-30 | 31.23 | $-3.68 | 0.00 |
| 2018-03-31 | 26.88 | $-3.61 | 0.00 |
| 2017-12-31 | 25.06 | $-3.26 | 0.00 |
| 2017-09-30 | 27.96 | $-4.19 | 0.00 |
| 2017-06-30 | 30.90 | $-6.33 | 0.00 |
| 2017-03-31 | 27.32 | $0.07 | 390.35 |
| 2016-12-31 | 26.06 | $2.08 | 12.53 |
| 2016-09-30 | 27.76 | $-0.32 | 0.00 |
| 2016-06-30 | 28.07 | $-0.34 | 0.00 |
| 2016-03-31 | 28.64 | $-2.88 | 0.00 |
| 2015-12-31 | 30.28 | $-13.35 | 0.00 |
| 2015-09-30 | 29.50 | $-12.97 | 0.00 |
| 2015-06-30 | 33.02 | $-15.79 | 0.00 |
| 2015-03-31 | 32.26 | $1.54 | 20.95 |
| 2014-12-31 | 28.78 | $27.88 | 1.03 |
| 2014-09-30 | 28.21 | $28.85 | 0.98 |
| 2014-06-30 | 24.89 | $31.38 | 0.79 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.853B | $1.346B |
| Premier, Inc. operates as a healthcare alliance. The company brings together hospitals, health systems, physicians and other healthcare providers primarily in the United States. It also maintains clinical, financial and outcomes databases. Premier, Inc. is headquartered in Charlotte, North Carolina. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.512B | 27.48 |
| Elevance Health (ELV) | United States | $86.065B | 11.11 |
| CVS Health (CVS) | United States | $83.137B | 10.33 |
| Cencora (COR) | United States | $55.558B | 19.33 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Natera (NTRA) | United States | $22.771B | 0.00 |
| BioMerieux (BMXMF) | France | $16.981B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.266B | 0.00 |
| Solventum (SOLV) | United States | $12.874B | 13.63 |
| ICON (ICLR) | Ireland | $11.753B | 10.93 |
| CochLear (CHEOY) | Australia | $11.492B | 0.00 |
| Revvity (RVTY) | United States | $11.324B | 19.49 |
| Doximity (DOCS) | United States | $10.794B | 49.97 |
| Viatris (VTRS) | United States | $10.540B | 3.62 |
| Avantor (AVTR) | United States | $9.213B | 13.39 |
| HealthEquity (HQY) | United States | $9.042B | 39.61 |
| Medpace Holdings (MEDP) | United States | $8.689B | 23.08 |
| Sonic Healthcare (SKHHY) | Australia | $8.397B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.422B | 14.54 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.425B | 26.06 |
| BrightSpring Health Services (BTSG) | United States | $3.848B | 35.31 |
| Sotera Health (SHC) | United States | $3.423B | 19.45 |
| Alignment Healthcare (ALHC) | United States | $3.055B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.969B | 38.62 |
| Concentras Parent (CON) | United States | $2.811B | 16.24 |
| Organon (OGN) | United States | $2.620B | 2.78 |
| GeneDx Holdings (WGS) | United States | $2.006B | 77.28 |
| Ardent Health (ARDT) | United States | $1.908B | 8.13 |
| Progyny (PGNY) | United States | $1.859B | 40.92 |
| GoodRx Holdings (GDRX) | United States | $1.618B | 32.36 |
| PACS (PACS) | United States | $1.615B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.302B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.222B | 9.29 |
| CareDx (CDNA) | United States | $1.118B | 17.46 |
| Establishment Labs Holdings (ESTA) | $1.114B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.948B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.844B | 7.90 |
| QDM (QDMI) | Hong Kong, SAR China | $0.763B | 0.00 |
| Nutex Health (NUTX) | United States | $0.671B | 10.16 |
| Embecta (EMBC) | United States | $0.591B | 3.98 |
| LifeMD (LFMD) | United States | $0.574B | 0.00 |
| Enhabit (EHAB) | United States | $0.519B | 42.71 |
| InnovAge Holding (INNV) | United States | $0.514B | 0.00 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.462B | 10.40 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| Oncology Institute (TOI) | United States | $0.255B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.252B | 0.00 |
| Beauty Health (SKIN) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 25.50 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.111B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.109B | 0.00 |
| So-Young (SY) | China | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.077B | 0.00 |
| OncoCyte (OCX) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.058B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.052B | 0.00 |
| OpGen (OPGN) | United States | $0.050B | 0.00 |
| Biodesix (BDSX) | United States | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |